Hundreds contact BBC about mystery skin condition ‘hell’ – but doctors can’t agree it exists
Hundreds contact BBC about mystery skin condition ‘hell’ – but doctors can’t agree it exists
Two weeks ago, I published a BBC News article exploring a puzzling skin disorder that has sparked widespread discussion online, known as topical steroid withdrawal (TSW). While some view it as a severe form of eczema, others argue it represents a distinct condition. This discrepancy has left healthcare professionals divided, and the piece resonated deeply with readers, drawing over 240 responses. Now, I’ve delved further into the issue, speaking with patients and experts to uncover why this condition remains so contentious.
A mother’s desperate choice
Bethany Norman, 36, recalled her anguish as she clutched her newborn son in a hospital bed, her arms wrapped in bandages. Her child had eczema, yet she refused steroid creams, defying medical advice. “See what this treatment did to me? Why would I use it on my own son?” she exclaimed, reflecting on her decision. For Bethany, years of relying on steroid creams to manage her lifelong eczema had led to a harrowing experience: raw skin, an unrelenting itch, and relentless flaking. She felt trapped in her own body, fearing her son might suffer the same fate.
“I’ve been told by countless medics that all I have is a severe flare-up of eczema and steroid creams will fix it. They just made it worse,” Bethany said.
Since the 1950s, steroid creams have been a cornerstone of eczema treatment, offering relief to millions. Available in mild over-the-counter forms like hydrocortisone or stronger prescription versions, these creams are widely trusted. However, a growing number of patients report that they no longer respond to steroids, sparking debates about their long-term effects.
Medical uncertainty and patient frustration
In 2021, the MHRA, the UK’s medicines regulator, acknowledged TSW as a possible reaction to prolonged steroid use—but not as an official diagnosis. This lack of consensus has fueled distrust between patients and doctors. “Communication can break down,” explained Dr. Pippa Bowes, an urgent care specialist in Southampton with expertise in dermatology. “Some patients feel unheard, and even professionals struggle to grasp what’s happening.”
Jenna Crosbie, a trainee GP in north Wales, initially couldn’t fathom why a patient would reject steroids. Her training emphasized them as essential for eczema. Yet, after observing her own skin symptoms shift while working night shifts, she began questioning their role. “I saw a patient in A&E with TSW, and I thought it looked like the worst eczema I’d ever seen,” she said. “But now I understand their perspective.”
“I wouldn’t wish it on my worst enemy,” Jenna added.
Dr. Dean Eggit, a GP in Doncaster, highlights the risk of overprescribing steroids. “Doctors often see a rash and reach for creams without investigating the root cause,” he noted. “TSW can mimic eczema early on, making it hard to distinguish. This may lead to a cycle of worsening symptoms.”
Guidelines and the search for clarity
NICE recommends a structured approach to eczema treatment, starting with emollients before introducing steroids. However, the absence of clear follow-up protocols creates challenges. “When patients receive repeat steroid prescriptions, we need to monitor their use closely,” explained Dr. Adrian Hayter from the Royal College of GPs. “But without proper checks, the condition might go unnoticed.”
The debate over TSW continues, with patients advocating for recognition and doctors seeking more research. As the conversation grows, the line between treatment and side effect grows blurrier, leaving both sides grappling with uncertainty. For now, the mystery endures, but the voices of those affected are louder than ever.